Every scan, every lab result, every wearable reading you generate helps train AI models and develop new treatments. The companies that profit from your data are worth billions. You—the person who created it—earn exactly zero.
Swell is a protocol where patients, providers, and technicians earn automatic revenue every time their data is used for research or AI training. Transparent. Programmable. Fair.
Your scans, wearable data, and health surveys are yours. When a researcher licenses your anonymized data to train a diagnostic AI, you earn automatically.
Clinical annotations, diagnostic notes, and quality assessments make raw data 10x more valuable. Every enrichment you add increases the dataset's worth—and your share.
Access governed, high-quality datasets with clear provenance and consent. Fair compensation means sustainable, reliable supply.
AI companies need massive, consent-verified medical datasets. But today's data lives in silos, lacks provenance, and has no consent trail. The people who need the data can't get it. The people who have it don't benefit from sharing.
Swell fixes both sides. Transparent incentives unlock supply. Governed provenance builds buyer trust.
Smart contracts handle the complexity. You contribute data and collect earnings.
Medical images are uploaded through a connected system. Context—clinical notes, annotations, device data—gets attached automatically.
Each data asset becomes a governed digital token with built-in rights, provenance, and revenue-sharing rules.
When researchers license the data, smart contracts distribute earnings to every stakeholder. No middlemen.
Every tokenized piece of medical data is a droplet. As more people contribute, droplets pool into datasets. Datasets compound into insights. Insights become treatments. Treatments generate revenue that flows back to the people who made it possible.
Unified—a vendor-agnostic data management platform for eye care—is Swell's first source partner. Real providers, real patients, real imaging data already flowing through production systems. That's how you solve the cold-start problem.
But the protocol doesn't stop at eye care. Any health data system can become a source partner—EHRs, imaging platforms, wearable ecosystems, research networks. Every new source makes the whole network more valuable for everyone in it.
If advanced treatments, personalized medicine, and performance health generate fair revenue through transparent data markets, then basic care, diagnostics, and prevention can eventually cost nothing. That's the long game.
Sources